The SUMMIT trial will document safety and efficacy of tirzepatide in heart failure patients, and the SYNERGY-NASH trial will provide specific data on the benefit of treatment with tirzepatide in people with non-alcoholic steatohepatitis
it's a copper peptide that your body naturally creates to manage inflammation and repair tissue
Abstract: Pullar, J., Carr, A., & Vissers, M
GSH is also the precursor of phytochelatins (PCs) and the substrate of glutathione S-transferase (GST), which plays an important role in the resistance of plants to heavy metal toxicity [15]
August 2025: A growing body of scientific research says that Mounjaro and other GLP-1 drugs may lead to dangerous side effects that affect vision
Pharmas grip on pricing, prolonged development cycles, and lobbying power left patients with fewer choices